Skip to main content
Funded Studies

Toshiya Nishi, DVM

Principal Scientist at Takeda Pharmaceutical Company Limited

Location: Kanagawa Japan

Toshiya Nishi, DVM, has been consistently engaged in drug discovery and development for two decades in Takeda Pharmaceutical. During his career as a pharmacologist, Dr. Nishi has led multiple drug discovery programs in diverse therapeutic areas ranging from peripheral inflammatory diseases, cardiovascular diseases and neurological disorders. He is an inventor of soticlestat, a small molecule inhibitor of cholesterol 24-hydroxylase now in clinical trials for the treatment of developmental and epileptic encephalopathy. His latest publication describes the first disclosure of soticlestat and its pharmacological activity in a preclinical model of Alzheimer’s disease. Dr. Nishi is now overseeing various neuroscience drug discovery programs as a translational scientist in Takeda.


Associated Grants

  • Assessing Inhibition of NLRP3 to Reduce Brain Inflammation in Parkinson’s Disease

    2021


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.